abstract |
The present invention is directed to methods for inhibition of HIV reverse transcriptase, treatment of infection by HIV, prophylaxis of infection by HIV, and the treatment, prophylaxis and/or delay in the onset or progression of AIDS or ARC by administering a compound of structural Formula (I) or a pharmaceutically acceptable salt or co-crystal thereof, wherein X is -F or -Cl, less frequently than once daily. |